Patients excluded from the study did not differ from those included with regard to baseline characteristics (gender, age, CD4 count, antiretroviral use) or the proportion of TB cases confirmed by positive direct or concentrated smear results (p > 0.15 for all comparisons). The gene discussed is CD4; the disease is tuberculosis.